Biotin & Thiamine: A novel therapeutic strategy for Huntington’s Disease

Patent number:

WO/2021/058847 (EP, US)

No items found.

El metabolismo de la tiamina está alterado en la enfermedad de Huntington. Nuestros estudios in vivo muestran que el tratamiento con tiamina y biotina revierte los síntomas de la enfermedad. Actualmente estamos evaluando la seguridad y tolerabilidad del tratamiento combinado tiamina-biotina en un ensayo clínico multicéntrico con pacientes.

Countries:

Spain

Regions:

Community of Madrid

Centers:

CSIC, CIBERNED CENTRO DE INVESTIG BIOMEDICA EN RED ENFERMEDADES NEURODEGENERATIVAS

Other entities:

Sectors:

Health

Subsectors:

TRL Level:

TRL 5 – technology validated in relevant environment (industrially relevant environment in the case of key enabling technologies)

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

- Improve HD neuropathology, radiology and motor symptoms in mouse model - Proven safety and good tolerability in human Good treatment adherance in human - ODD eligible - Allows combination therapy with other treatments

Comments

Other related patents

Health

PLATELET FUNCTIONALITY FOR EARLY DIAGNOSIS OF PARKINSON'S DISEASE

Countries

Spain

Health

INHIBITORS OF BUNYAVIRIDAE AND USES THEREOF

Countries

Greece

Health

INTRACELLULAR DELIVERY OF ANTI-KRAS ANTIBODIES FORMULATED INTO NANOCAPSULES

Countries

Spain

Get back to patents directory